Candel Therapeutics Inc (CADL)
12.70
-1.30
(-9.29%)
USD |
NASDAQ |
May 16, 16:00
12.74
+0.04
(+0.31%)
After-Hours: 07:28
Candel Therapeutics Total Long Term Debt (Quarterly)
Total Long Term Debt (Quarterly) Chart
Historical Total Long Term Debt (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2022 | 20.85M |
| September 30, 2022 | 20.75M |
| June 30, 2022 | 20.63M |
| March 31, 2022 | 20.52M |
| December 31, 2021 | 0.56M |
| September 30, 2021 | 0.541M |
| Date | Value |
|---|---|
| June 30, 2021 | 0.521M |
| March 31, 2021 | 0.966M |
| December 31, 2020 | 0.946M |
| September 30, 2020 | 0.00 |
| June 30, 2020 | 0.00 |
| March 31, 2020 | 0.00 |
Total Long Term Debt Definition
Total Long Term Debt is the current and non-current portion of debt that a company holds. Current Portion debt are obligations of a company lasting shorter than a year. This is found in a company's current liabilities on its balance sheet.
Total Long Term Debt (Quarterly) Range, Past 5 Years
--
Minimum
Mar 2020
20.85M
Maximum
Dec 2022
7.191M
Average
0.753M
Median
Total Long Term Debt (Quarterly) Benchmarks
| Allurion Technologies Inc | 38.64M |
| AngioDynamics Inc | 0.00 |
| Eliem Therapeutics Inc | -- |
| Macrogenics Inc | 0.00 |
| GlycoMimetics Inc | -- |